CAS: 951130-92-0
Argatroban Impurity 51 Acetate
CAS:951130-92-0
Formula:
C23H32N6O5S·C2H4O2
Color and Shape:
White To Off-White Solid
Molecular weight:
504.61 60.05
Ref: 4Z-A-59106
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Argatroban Impurity 51
CAS:951130-92-0
Formula:
C23H32N6O5S
Color and Shape:
White To Off-White Solid
Molecular weight:
504.61
Ref: 4Z-A-595
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Argatroban Impurity 37
CAS:951130-92-0
Formula:
C23H33N7O5S
Color and Shape:
White To Off-White Solid
Molecular weight:
519.62
Ref: 4Z-A-5952
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
1,2,3,4-Tetradehydro Argatroban
Controlled ProductCAS:951130-92-0
Applications 1,2,3,4-Tetrahydro Argatroban is a metabolite of Argatroban (A769000); a synthetic thrombin inhibitor and antithrombotic. …
Formula:
C23H32N6O5S
Color and Shape:
Neat
Molecular weight:
504.60
Ref: TR-T293055
| 25mg | 1,231.00 € | ||
| 50mg | 1,928.00 € | ||
| 100mg | 3,170.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
1,2,3,4-Tetrahydro Argatroban-d8
Controlled ProductCAS:951130-92-0
Formula:
C23H24D8N6O5S
Color and Shape:
Neat
Molecular weight:
512.65
Ref: TR-T293057
| 25mg | 5,356.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
1,2,3,4-Tetradehydro argatroban
CAS:951130-92-0
Please enquire for more information about 1,2,3,4-Tetradehydro argatroban including the price, delivery time and more …
Formula:
C23H32N6O5S
Purity:
Min. 95%
Molecular weight:
504.6 g/mol
Ref: 3D-BNB13092
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
